Suzanne M. Hanlon, Secretary, VP & General Counsel at Zynerba Pharmaceuticals, Inc. (ZYNE), bought 3,800 shares at $5.80 ($22K) on 2018-08-06, disclosed to the SEC on 2018-08-07.
Open-market purchase of $22k ZYNE by Secretary, VP & General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |